Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Irritable Bowel Syndrome: HELP
Articles from Chile
Based on 6 articles published since 2008
||||

These are the 6 published articles about Irritable Bowel Syndrome that originated from Chile during 2008-2019.
 
+ Citations + Abstracts
1 Review [Parasitosis and irritable bowel syndrome]. 2016

Ibarra, Catalina / Herrera, Valentina / Pérez de Arce, Edith / Gil, Luis Carlos / Madrid, Ana María / Valenzuela, Lucía / Beltrán, Caroll J. ·Facultad de Medicina, Universidad de Chile, Chile. · Servicio de Gastroenterología, Hospital Clínico, Universidad de Chile, Chile. · Laboratorio de Enfermedades Funcionales Digestivas, Servicio de Gastroenterología, Hospital Clínico, Universidad de Chile, Chile. · Laboratorio de Inmuno-Gastroenterología, Servicio de Gastroenterología, Hospital Clínico, Universidad de Chile, Chile, cbeltran@med.uchile.cl. ·Rev Chilena Infectol · Pubmed #27598274.

ABSTRACT: Irritable bowel syndrome (IBS) is a functional disorder of the gastrointestinal tract characterised by multi-factorial aetiology. In IBS physiopathology are involved diverse factors between them biological, psychosocial, and environmental components which affect the immune activation status of gut mucosa. Among these factors is recognized the intestinal parasitosis. Post-infection IBS (PI-IBS) is recognised as a subgroup of functional disorders whose symptoms onset appear after a symptomatic intestinal infection caused by microbial agents. There are few studies regarding of relationship between IBS and intestinal parasitosis in Chile. However, is has been well described a positive association between IBS and Blastocystis hominis infections, one of prevalent parasites in Chile. In other countries, is also described a relationship between IBS and amebiasis and giardiasis. Both, characterized by a common mode of transmission through water as well as contaminated food. Because the high prevalence of parasitosis in our country it is necessary to expand the association studies to clarify the strength of the parasites ethiology in IBS.

2 Review Communication between gastrointestinal bacteria and the nervous system. 2012

Bravo, Javier A / Julio-Pieper, Marcela / Forsythe, Paul / Kunze, Wolfgang / Dinan, Timothy G / Bienenstock, John / Cryan, John F. ·Instituto de Química, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile. javier.bravo@ucv.cl ·Curr Opin Pharmacol · Pubmed #23041079.

ABSTRACT: In the past few years, intestinal microbiota has emerged as a novel target for the treatment of gut-brain axis alterations. These include functional gastrointestinal disorders, such as irritable bowel syndrome (IBS), which can be comorbid with stress-related psychiatric conditions. Thus, modulation of the microbiota (e.g. with the use of probiotics) could be proposed as a novel strategy not only for the treatment of IBS but also as an adjuvant for psychiatric treatment of anxiety and depression.

3 Review [Constipation in adults: an update]. 2008

Cofré L, Pamela / Germain P, Fernando / Medina L, Luis / Orellana G, Hernán / Suárez M, Juan / Vergara A, Teresa. ·Departamento de Gastroenterología, Hospital Naval Almirante Nef, Viña del Mar, Chile. pamecoli@hotmail.com ·Rev Med Chil · Pubmed #18769795.

ABSTRACT: Constipation affects 2% to 27% of individuals. It is associated to irritable bowel syndrome in 59% of cases, to a pelvic floor dysfunction in 29% and to a low transit time in 13%. During assessment of patients with constipation the effects of medications and chronic diseases must be discarded and the ideal is to determine which type of functional disorder it present. An algorithm for the management of chronic idiopathic constipation, that includes a recommendation to increase fiber and liquid intake as an initial approach and an orientation to the use of different laxatives, is presented. The usefulness of biofeedback in patients with pelvic floor dysfunction and without organic cause of constipation, is also discussed.

4 Article A Retrospective Study on Dietary FODMAP Intake in Celiac Patients Following a Gluten-Free Diet. 2018

Roncoroni, Leda / Elli, Luca / Doneda, Luisa / Bascuñán, Karla A / Vecchi, Maurizio / Morreale, Federico / Scricciolo, Alice / Lombardo, Vincenza / Pellegrini, Nicoletta. ·Center for Prevention and Diagnosis of Celiac Disease, Gastroenterology and Endoscopy Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 20122 Milan, Italy. leda.roncoroni@unimi.it. · Department of Biomedical, Surgical and Dental Sciences, University of Milan, 20131 Milan, Italy. leda.roncoroni@unimi.it. · Center for Prevention and Diagnosis of Celiac Disease, Gastroenterology and Endoscopy Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 20122 Milan, Italy. lucelli@yahoo.it. · Department of Biomedical, Surgical and Dental Sciences, University of Milan, 20131 Milan, Italy. luisa.doneda@unimi.it. · Center for Prevention and Diagnosis of Celiac Disease, Gastroenterology and Endoscopy Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 20122 Milan, Italy. kbascunan@med.uchile.cl. · Department of Nutrition, University of Chile, 8380453 Santiago, Chile. kbascunan@med.uchile.cl. · Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy. maurizio.vecchi@policlinico.mi.it. · Gastroenterology and Endoscopic Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 20122 Milan, Italy. maurizio.vecchi@policlinico.mi.it. · Human Nutrition Unit, Department of Food and Drug, University of Parma, 43121 Parma, Italy. morreale.federico@gmail.com. · Center for Prevention and Diagnosis of Celiac Disease, Gastroenterology and Endoscopy Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 20122 Milan, Italy. scricciolo.alice@gmail.com. · Center for Prevention and Diagnosis of Celiac Disease, Gastroenterology and Endoscopy Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 20122 Milan, Italy. vicky.l@hotmail.it. · Human Nutrition Unit, Department of Food and Drug, University of Parma, 43121 Parma, Italy. nicoletta.pellegrini@unipr.it. ·Nutrients · Pubmed #30445688.

ABSTRACT: Our aim was to evaluate the intake of foods containing fermentable oligo/di/mono-saccharides and polyols (FODMAP) as a possible factor that induces gastrointestinal symptoms in treated celiac disease (CD) patients. We collected seven-day weighed food records for 104 CD patients and 91 healthy volunteers. All evaluated food items were from sources with high and low content of FODMAP, which were divided into cereals and sweets, sweeteners and soft drinks, fruits, dried fruits, and vegetables. Nutrient intake was calculated using the food database of the European Institute of Oncology. The symptoms reported were assessed by a Rome IV Irritable bowel syndrome (IBS) diagnostic questionnaire and by specific questions for the evaluation of functional gastrointestinal disorders (FGIDs). The 12% of CD patients met IBS symptoms criteria as opposed to 6% of controls (

5 Article [Irritable bowel syndrome subtypes and characteristics in children from Panama, Ecuador,El Salvador, Nicaragua and Mexico]. 2018

Velasco-Benítez, Carlos Alberto / Chanís, Ricardo / Játiva, Edgar / Zablah, Roberto / Mejía, Milton / Rodriguez Reynosa, Laura / Leyva Jimenez, Sofia Araceli. ·Universidad del Valle. Cali, Colombia. · Hospital del Niño. Ciudad de Panamá, Panamá. · Universidad Central del Ecuador. Quito, Ecuador; Universidad de la Frontera. Temuco, Chile. · Departamento de Gastroenterología y Endoscopía, Hospital Nacional de Niños Benjamín Bloom. San Salvador, El Salvador. · Hospital Nacional de Niños de Nicaragua. Managua, Nicaragua. · Instituto Mexicano del Seguro Social. Monterrey, México; Hospital de Especialidades Clínica No. 25 IMSS. Monterrey, México. · Servicios de Gastroenterología, Hospital del Niño y del Adolescente Morelense en Cuernavaca. Morelos, México. ·Rev Gastroenterol Peru · Pubmed #30118458.

ABSTRACT: INTRODUCTION: Few pediatric studies classify the irritable bowel syndrome (IBS) subtypes. OBJECTIVE: To describe the characteristics and subtypes of IBS in children from Panama, Ecuador, El Salvador, Nicaragua and Mexico. MATERIAL AND METHODS: Prevalence study performed in children between 8 and 18 years of age with a diagnosis of IBS. The children answered the Questionnaire for Pediatric Gastrointestinal Symptoms Roma III for Schoolchildren and Adolescents (QPGS-III) to identify functional gastrointestinal disorders. Variables such as age and sex were taken into account. The subtypes of IBS were classified in IBS with constipation (IBS-c), with diarrhea (IBS-d), mixed (IBS-m) and without subtype (IBS-ss). Statistical analysis included measures of central tendency, two-tailed student t-test, chi-square test, and Fisher's exact test, with a significant p<0.05. RESULTS: We included 79 children (54.4% female, 12.1±2.1 years) presenting IBS-ss in 55.7%, IBS-c in 15.2%, IBS-m in 15.2% and SII-d in 13.9%. Severe pain predominated most of the day and with mucous stools; possible associations for IBS-d school and sex. CONCLUSION: After IBS-ss, the IBS-e, IBS-d and IBS-m are similar, being the possible risk factors for IBS-d, the public school and the female gender.

6 Article [The prevalence of irritable bowel symptoms in a population of shopping mall visitors in Santiago de Chile]. 2013

Madrid-Silva, A M / Defilippi-Caffri, C / Landskron-Ramos, G / Olguín-Herrera, F / Reyes-Ponce, A / Castro-Lara, A / Larraín-Corp, S / Martínez-Roje, N / Cortés-Espinoza, J. ·Laboratorio de Enfermedades Funcionales Digestivas, Hospital Clínico Universidad de Chile, Santiago, Chile. Electronic address: anamariamadrid@gmail.com. · Programa de Fisiología, ICBM, Facultad de Medicina, Universidad de Chile, Santiago, Chile. · Laboratorio de Enfermedades Funcionales Digestivas, Hospital Clínico Universidad de Chile, Santiago, Chile. · Departamento de Cirugía, Hospital Clínico Universidad de Chile, Santiago, Chile. · Oficina de Apoyo a la Investigación Clínica, Hospital Clínico Universidad de Chile, Santiago, Chile. · Escuela de Medicina, Facultad de Medicina, Universidad de Chile, Santiago, Chile. ·Rev Gastroenterol Mex · Pubmed #24290320.

ABSTRACT: BACKGROUND: Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by abdominal pain or discomfort that is associated with altered bowel habit. Both its prevalence and clinical characteristics vary throughout Latin America. A percentage of patients does not seek medical attention, therefore a reliable prevalence figure can only be established by interviewing non-selected populations. AIMS: To study the prevalence and clinical characteristics of IBS symptoms in non-selected subjects in Santiago, Chile. METHODS: A total of 437 shopping mall visitors above the age of 15 years (246 women) participated in the study by answering the Rome II validated questionnaire for IBS. The demographic and socioeconomic backgrounds, comorbidities, and a family history of IBS were registered. RESULTS: A total of 64.1% subjects reported having gastrointestinal symptoms and 28.6% had symptoms suggestive of IBS. When the subjects with IBS symptoms were compared with the asymptomatic individuals, a predominance of women (65.6 vs. 42.9, P<.001) and a greater cholecystectomy frequency (33.6 vs. 12.9% P<.05) were observed in the former. The age of symptom onset was 30.4 years. An equal percentage of subjects (42.4%) presented with diarrhea and constipation and 15.2% presented with alternating IBS. Participants with a higher educational level reported a lower percentage of IBS (P<.05). A family history of the disease was present in 40% of the subjects with IBS, compared with 14.9% in the asymptomatic individuals (P<.05). Only 39.2% of the subjects had seen a physician for their symptoms and the treatment and tests ordered were inappropriate. CONCLUSION: The prevalence of IBS symptoms in the population studied is one of the highest described. Therefore, health teams should have the necessary knowledge and skill required for its management.